We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Ignyta Receives FDA Investigational Device Exemption

News   Sep 01, 2016

 
Ignyta Receives FDA Investigational Device Exemption
 
 
Advertisement
 

RELATED ARTICLES

UK Government-Funded COVID-19 Vaccine Phase 1/2 Trials Report Positive Data

News

A new COVID-19 vaccine candidate – VLA2001 – developed by Valneva has shown positive results in a UK Government-funded Phase I/II clinical trial, according to a press release.

READ MORE

Super-Enhancers That Switch on Breast Cancer Genes Discovered

News

A research team has identified and characterized a set of specific super-enhancers that stimulate the activity of related critical cancer genes. The research has also discovered that the deletion of certain specific super-enhancers can reduce tumor cell growth.

READ MORE

Damage-Sensing Proteins Recognize DNA Breaks

News

Researchers have exploited cryogenic electron microscopy to visualize mechanisms behind DNA damage, by illuminating the mysterious cycle of DNA breakage sensing and repair.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE